|
시장보고서
상품코드
1652092
세계의 관절내 보충 요법 시장 규모, 점유율, 동향, 업계 분석 : 제품별, 최종 용도별, 지역별 - 예측(2025-2034년)Viscosupplementation Market Size, Share, Trends, Industry Analysis Report: By Product, End Use, and Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면 세계의 관절내 보충 요법 시장 규모는 2034년까지 152억 6,000만 달러에 달할 전망입니다. 이 리포트는 현재 시장 역학의 상세 인사이트와 향후 시장 성장에 관한 분석을 제공하고 있습니다.
무릎 관절내 치환술 시장은 무릎 관절염(OA)의 유병률 증가와 비수술적 치료 옵션에 대한 수요 증가로 인해 크게 성장하고 있습니다. 관절내 치환술은 무릎 관절에 히알루론산을 주입하여 통증을 완화하고 운동성을 개선하는 치료법으로, 경증에서 중등도의 OA 환자들에게 널리 사용되고 있습니다. 이 시장은 전 세계 인구의 고령화, 관절 건강에 대한 인식 증가, 그리고 편리성과 효능을 향상시키는 1회 주입형 및 가교형과 같은 히알루론산 제제의 발전으로 혜택을 누리고 있습니다.
인공관절 치환술을 대체할 수 있는 최소침습적 치료의 채택 증가는 인공관절 치환술 시장 확대의 주요 촉진요인 중 하나입니다. 유럽과 북미와 같은 지역에서의 우호적인 상환 정책과 신흥 국가에서의 의료 접근성 개선은 시장 수요를 더욱 촉진하고 있습니다. 기술 발전과 보다 효과적인 제형에 대한 지속적인 연구는 기존 기업과 신규 진출기업 모두에게 큰 시장 기회를 제공합니다.
관절내장비료 시장은 지속적인 성장세를 보이고 있으며, 주요 기업은 혁신과 전략적 제휴에 투자하여 진화하는 환자 니즈에 대응하고 새로운 기회를 활용함으로써 골관절염 관리에 필수적인 요소로서의 역할을 강화하고 있습니다.
고령 인구 증가, 가처분 소득 증가, 의료 인프라 개선 등을 배경으로 아시아태평양의 강력한 성장이 기대되는 등 시장 전망은 밝습니다. 그러나 가격 압력, 대체 치료와의 경쟁, 규제 장애물 등의 과제는 여전히 남아있습니다.
관절내장비료 시장 : 분석 개요
제품별로는 무릎 골관절염 관리에 있으며, 효과가 입증되고, 널리 보급되어 있으며, 의료진들이 선호하는 3주 주사제가 2024년 가장 큰 시장 점유율을 차지했습니다.
최종 용도별로는 정형외과 클리닉/ASC 부문이 예측 기간 중 가장 빠른 성장을 보일 것으로 예상되는데, 이는 이러한 환경에서 제공되는 전문적이고 비용 효율적이며 최소 침습적인 치료에 대한 환자 선호도가 높아졌기 때문입니다.
2024년 아시아태평양은 고령화 인구가 많고 무릎 골관절염의 유병률이 증가함에 따라 관절내 치환술 시장에서 가장 큰 점유율을 차지하고 있습니다.
유럽의 관절내 치환술 시장은 고급 골관절염 치료에 대한 수요 증가로 인해 예측 기간 중 가장 빠른 CAGR을 나타낼 것으로 예상됩니다.
세계의 주요 기업에는 Anika Therapeutics, Inc., DePuy Synthes, F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals B.V., Fidia Farmaceutici S.p.A, LG Life Sciences Ltd., Lifecore Biomedical, Sanofi, 생화학 산업, 스미스·앤드·네퓨 PLC, Zimmer Biomet 등이 있습니다.
목차
제1장 서론
제2장 개요
제3장 분석 방법
제4장 관절내 보충 요법 시장 인사이트
- 시장 스냅숏
- 관절내 보충 요법 시장 역학
- 촉진요인과 기회
- 슬관절증의 이환율 상승
- 고령화 인구의 증가
- 억제요인과 과제
- 고액의 치료비
- 촉진요인과 기회
- PESTLE 분석
- 관절내 보충 요법 시장 동향 : 용도별
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 관절내 보충 요법 시장 : 제품별
- 주요 조사 결과
- 서론
- 3회 주사식
- 5회 주사식
- 단회 주사식
제6장 세계의 관절내 보충 요법 시장 : 최종 용도별
- 주요 조사 결과
- 서론
- 정형외과 클리닉/외래 수술 센터(ASC)
- 병원
제7장 세계의 관절내 보충 요법 시장 : 지역별
- 주요 분석 결과
- 서론
- 관절내 보충 요법 시장 평가 : 지역별(2020-2034년)
- 북미
- 북미 : 제품별(2020-2034년)
- 북미 : 최종 용도별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 제품별(2020-2034년)
- 유럽 : 최종 용도별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 제품별(2020-2034년)
- 아시아태평양 : 최종 용도별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 제품별(2020-2034년)
- 중동 및 아프리카 : 최종 용도별(2020-2034년)
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 제품별(2020-2034년)
- 라틴아메리카 : 최종 용도별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제8장 경쟁 구도
- 사업 확대·기업 인수 분석
- 사업 확대
- 기업 인수
- 제휴/협업/합의/공개
제9장 기업 개요
- Anika Therapeutics, Inc.
- DePuy Synthes
- F.Hoffmann-La Roche Ltd.
- Ferring Pharmaceuticals B.V.
- Fidia Farmaceutici S.p.A
- LG Life Sciences Ltd.
- Lifecore Biomedical
- Sanofi
- Seikagaku Corp.
- Smith & Nephew PLC
- Zimmer Biomet
The global viscosupplementation market size is expected to reach USD 15.26 billion by 2034, according to a new study by Polaris Market Research. The report "Viscosupplementation Market Size, Share, Trends, Industry Analysis Report: By Product (Three Injection, Five Injection, and Single Injection), End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The viscosupplementation market is experiencing significant growth, driven by the rising prevalence of knee osteoarthritis (OA) and increasing demand for non-surgical treatment options. Viscosupplementation, which involves injecting hyaluronic acid into the knee joint to alleviate pain and improve mobility, has gained widespread acceptance among patients with mild to moderate OA. The market is benefitting from an aging global population, growing awareness of joint health, and advancements in hyaluronic acid formulations, such as single-injection and cross-linked variants, which enhance convenience and efficacy.
The increasing adoption of minimally invasive treatments that offer an alternative to joint replacement surgery is one of the key drivers of the viscosupplementation market expansion. Favorable reimbursement policies in regions like Europe and North America, along with improving healthcare access in emerging economies, have further boosted market demand. Technological advancements and ongoing research into more effective formulations present significant market opportunities for both established players and new entrants.
The viscosupplementation market is poised for sustained market growth, with key players investing in innovation and strategic partnerships to address evolving patient needs and capitalize on emerging opportunities, reinforcing its role as a vital component of osteoarthritis management.
The market outlook is positive, with robust growth expected in Asia Pacific, driven by large elderly populations, rising disposable income, and enhanced healthcare infrastructure. However, challenges such as pricing pressure, competition from alternative treatments, and regulatory hurdles remain.
Key Highlights of Viscosupplementation Market Report
In terms of product, in 2024, the three injection segment accounted for the largest market share due to its established efficacy, widespread availability, and preference among healthcare providers for managing knee osteoarthritis.
Based on end use, the orthopedic clinics/ASCs segment is expected to witness the fastest growth during the forecast period due to increasing patient preference for specialized, cost-effective, and minimally invasive treatments offered in these settings.
In 2024, Asia Pacific accounted for the largest share of the viscosupplementation market due to the region's large aging population and increasing prevalence of knee osteoarthritis.
The Europe viscosupplementation market is expected to witness the fastest CAGR during the forecast period due to increasing demand for advanced osteoarthritis treatments.
A few global key market players include Anika Therapeutics, Inc.; DePuy Synthes; F. Hoffmann-La Roche Ltd.; Ferring Pharmaceuticals B.V.; Fidia Farmaceutici S.p.A, LG Life Sciences Ltd.; Lifecore Biomedical; Sanofi; Seikagaku Corp.; Smith & Nephew PLC; and Zimmer Biomet.
Polaris Market Research has segmented the viscosupplementation market research report on the basis of product, end use, and region:
By Product Outlook (Revenue - USD Billion, 2020-2034)
- Three Injection
- Five Injection
- Single Injection
By End Use Outlook (Revenue - USD Billion, 2020-2034)
- Orthopedic Clinics/ASCs
- Hospitals
By Regional Outlook (Revenue - USD Billion, 2020-2034)
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Australia
- Vietnam
- Rest of Asia Pacific
- Latin America
- Argentina
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
- Rest of Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Viscosupplementation Market Insights
- 4.1. Viscosupplementation Market - Market Snapshot
- 4.2. Viscosupplementation Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Prevalence of Knee Osteoarthritis
- 4.2.1.2. Growing Aging Population
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Treatment Costs
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Viscosupplementation Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Viscosupplementation Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 5.3. Three Injection
- 5.3.1. Global Viscosupplementation Market, by Three Injection, by Region, 2020-2034 (USD Billion)
- 5.4. Five Injection
- 5.4.1. Global Viscosupplementation Market, by Five Injection, by Region, 2020-2034 (USD Billion)
- 5.5. Single Injection
- 5.5.1. Global Viscosupplementation Market, by Single Injection, by Region, 2020-2034 (USD Billion)
6. Global Viscosupplementation Market, by End Use
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 6.3. Orthopedic Clinics/ASCs
- 6.3.1. Global Viscosupplementation Market, by Orthopedic Clinics/ASCs, by Region, 2020-2034 (USD Billion)
- 6.4. Hospitals
- 6.4.1. Global Viscosupplementation Market, by Hospitals, by Region, 2020-2034 (USD Billion)
7. Global Viscosupplementation Market, by Geography
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Viscosupplementation Market Assessment, By Geography, 2020-2034 (USD Billion)
- 7.3. Viscosupplementation Market - North America
- 7.3.1. North America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.3.2. North America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.3.3. Viscosupplementation Market - U.S.
- 7.3.3.1. U.S.: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.3.3.2. U.S.: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.3.4. Viscosupplementation Market - Canada
- 7.3.4.1. Canada: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.3.4.2. Canada: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4. Viscosupplementation Market - Europe
- 7.4.1. Europe: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.4.2. Europe: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.3. Viscosupplementation Market - UK
- 7.4.3.1. UK: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.4.3.2. UK: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.4. Viscosupplementation Market - France
- 7.4.4.1. France: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.4.4.2. France: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.5. Viscosupplementation Market - Germany
- 7.4.5.1. Germany: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.4.5.2. Germany: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.6. Viscosupplementation Market - Italy
- 7.4.6.1. Italy: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.4.6.2. Italy: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.7. Viscosupplementation Market - Spain
- 7.4.7.1. Spain: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.4.7.2. Spain: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.8. Viscosupplementation Market - Netherlands
- 7.4.8.1. Netherlands: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.4.8.2. Netherlands: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.9. Viscosupplementation Market - Russia
- 7.4.9.1. Russia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.4.9.2. Russia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.10. Viscosupplementation Market - Rest of Europe
- 7.4.10.1. Rest of Europe: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.4.10.2. Rest of Europe: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5. Viscosupplementation Market - Asia Pacific
- 7.5.1. Asia Pacific: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.5.2. Asia Pacific: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.3. Viscosupplementation Market - China
- 7.5.3.1. China: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.5.3.2. China: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.4. Viscosupplementation Market - India
- 7.5.4.1. India: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.5.4.2. India: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.5. Viscosupplementation Market - Malaysia
- 7.5.5.1. Malaysia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.5.5.2. Malaysia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.6. Viscosupplementation Market - Japan
- 7.5.6.1. Japan: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.5.6.2. Japan: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.7. Viscosupplementation Market - Indonesia
- 7.5.7.1. Indonesia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.5.7.2. Indonesia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.8. Viscosupplementation Market - South Korea
- 7.5.8.1. South Korea: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.5.8.2. South Korea: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.9. Viscosupplementation Market - Australia
- 7.5.9.1. Australia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.5.9.2. Australia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.10. Viscosupplementation Market - Rest of Asia Pacific
- 7.5.10.1. Rest of Asia Pacific: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.5.10.2. Rest of Asia Pacific: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.6. Viscosupplementation Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.6.2. Middle East & Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.6.3. Viscosupplementation Market - Saudi Arabia
- 7.6.3.1. Saudi Arabia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.6.3.2. Saudi Arabia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.6.4. Viscosupplementation Market - UAE
- 7.6.4.1. UAE: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.6.4.2. UAE: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.6.5. Viscosupplementation Market - Israel
- 7.6.5.1. Israel: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.6.5.2. Israel: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.6.6. Viscosupplementation Market - South Africa
- 7.6.6.1. South Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.6.6.2. South Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.6.7. Viscosupplementation Market - Rest of Middle East & Africa
- 7.6.7.1. Rest of Middle East & Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.6.7.2. Rest of Middle East & Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.7. Viscosupplementation Market - Latin America
- 7.7.1. Latin America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.7.2. Latin America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.7.3. Viscosupplementation Market - Mexico
- 7.7.3.1. Mexico: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.7.3.2. Mexico: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.7.4. Viscosupplementation Market - Brazil
- 7.7.4.1. Brazil: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.7.4.2. Brazil: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.7.5. Viscosupplementation Market - Argentina
- 7.7.5.1. Argentina: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.7.5.2. Argentina: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.7.6. Viscosupplementation Market - Rest of Latin America
- 7.7.6.1. Rest of Latin America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.7.6.2. Rest of Latin America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
- 9.1. Anika Therapeutics, Inc.
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. DePuy Synthes
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. F.Hoffmann-La Roche Ltd.
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Ferring Pharmaceuticals B.V.
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Fidia Farmaceutici S.p.A
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. LG Life Sciences Ltd.
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Lifecore Biomedical
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Sanofi
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Seikagaku Corp.
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Smith & Nephew PLC
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. Zimmer Biomet
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
